RBC Capital analyst Scott Hanold downgrades EOG Resources (NYSE:EOG) from Outperform to Sector Perform.
Codexis Shares Up Following Reports China Is In Talks For Paxlovid Generic; Codexis In 2022 Announced Agreement With Pfizer To Supply Enzyme For The Manufacture Of Paxlovid
https://www.codexis.com/investors/news-events/press-releases/detail/330/codexis-announces-agreement-with-pfizer-to-supply